Interius BioTherapeutics Launches Innovative Gene Therapy Trial for B-Cell Malignancies
PHILADELPHIA, PA — Interius BioTherapeutics has taken a significant step forward with the dosing of its first participant in the Phase 1 clinical trial of INT2104, a pioneering gene therapy designed …
Interius BioTherapeutics Launches Innovative Gene Therapy Trial for B-Cell Malignancies Read More